Global Exosome Research Markets 2022-2026

DUBLINMay 23, 2022 /PRNewswire/ — The “Global Exosome Research Market by product and services (kits, reagents, instrument), indication (cancer, infectious diseases), application (biomarkers, vaccines), manufacturing services (stem cell, dendritic cell-derived), End-user and region – Forecast to 2026″ has been added to: ResearchAndMarkets.com’s offer.

Research_and_Markets_Logo

Research_and_Markets_Logo

The global exosome research market is estimated to be USD 144 million in 2021 and is expected to reach USD 661 million by 2026, at a CAGR of 35.6% over the forecast period, due to increased funding for life sciences research, the high global prevalence of cancer and increasing interest in exosome-based procedures.

By product and service, the kits and reagents segment accounted for the majority of the exosome research market

Based on product and service, the exosomes market is segmented into kits and reagents, instruments and services. The kits and reagents segment is further divided into antibodies, isolation, purification, quantitation kits and reagents, and other kits and reagents.

Circulating exosomal microRNAs (miRNAs) have emerged as valuable biomarker candidates, making it necessary to carefully characterize these exosomes. This has stimulated the use of these entities in exosome research to develop easy-to-use kits and reagents. Moreover, isolation and purification are critical steps in exosome research protocols, contributing to their large-scale acceptance in the market.

Asia-Pacific: The fastest growing region in the exosome research market

The Asia-Pacific exosome research market has been registered to grow at the fastest pace during the forecast period. Rising disposable income, infrastructure developments and the penetration of advanced diagnostic technologies in Asian countries such as India and China offer significant growth opportunities for exosome manufacturers and distributors.

North America: De North America region accounts for the largest share of the exosome research market

North America accounts for the bulk of the exosome research market. The US provides the main source of income to the North American exosome research market. The high prevalence of cancer coupled with the increasing demand for early and effective disease diagnosis and treatment is the main factor driving market growth in the US.

Competitive landscape

Thermo Fisher Scientific (USA), QIAGEN NV (The Netherlands), Bio-Techne (USA), System Biosciences, LLC. (US), NX PharmaGen (US), Miltenyi Biotec (Germany), AMS Biotechnology (Europe) Limited (UK), NanoSomiX (US), Lonza (Switzerland), and Norgen Biotek Corp. †Canada) are some of the leading players in the global exosome research market.

Premium Insights

  • Rising investment in the pharmaceutical industry to support market growth

  • Kits and reagents segment accounted for the largest share of the North American exosome research market in 2020

  • Lung cancer segment to dominate the market in 2026

Market dynamics

drivers

limits

Opportunities

  • untapped emerging markets

  • Growing interest in exosome-based therapies

  • High demand for personalized medicine

Challenge

Impact of COVID-19 outbreak on exosome research market

Ecosystem and Value Chain Analysis

Regulatory Analysis

Featured companies

  • Aethlon Medical, Inc.

  • AMSBio (Ams Biotechnology)

  • Anjarium Biosciences AG

  • Bio-Techne

  • Biovision Inc.

  • Cell Guidance Systems LLC

  • Ciloa

  • Clara Biotech, Inc.

  • Creative Medical Technology Holdings, Inc.

  • eversom

  • Exofarm

  • Ilias Biologics, Inc.

  • Inoviq (Bard1 Life Sciences Ltd.)

  • Lonza

  • Miltenyi Biotec

  • Nanosomix, Inc.

  • Nanoview Life Sciences

  • Norgen Biotek Corp.

  • Novus Biologicals

  • NX Pharmagen

  • Pall Corporation

  • qiagen

  • Rion, LLC

  • System Biosciences, LLC

  • Thermo Fisher Scientific, Inc.

For more information on this report, please visit https://www.researchandmarkets.com/r/16glrr

Media contact:

Research and markets
Laura Woodsenior manager
[email protected]

For EST business hours, call +1-917-300-0470
For US/CAN Toll Free Call +1-800-526-8630
For GMT office hours, please call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716

decision

decision

View Original Content: https://www.prnewswire.com/news-releases/global-exosome-research-markets-2022-2026—opportunities-in-untapped-emerging-markets-growing-interest-in-exosome- based-therapeutics–high-demand-for-personalized-medicine-301552728.html

SOURCE Research and markets

Leave a Comment